RnA ReSet Pro Revenue and Competitors
Estimated Revenue & Valuation
- RnA ReSet Pro's estimated annual revenue is currently $3.1M per year.
- RnA ReSet Pro's estimated revenue per employee is $162,000
Employee Data
- RnA ReSet Pro has 19 Employees.
- RnA ReSet Pro grew their employee count by 6% last year.
RnA ReSet Pro's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Account Manager | Reveal Email/Phone |
RnA ReSet Pro Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.1M | 1 | 0% | N/A | N/A |
#2 | $20.5M | 76 | 0% | N/A | N/A |
#3 | $7.6M | 35 | 6% | N/A | N/A |
#4 | $1.1M | 8 | -80% | N/A | N/A |
#5 | $5.5M | 29 | 0% | N/A | N/A |
#6 | $0.7M | 5 | 0% | N/A | N/A |
#7 | $21.3M | 79 | 7% | N/A | N/A |
#8 | $31.1M | 115 | 53% | N/A | N/A |
#9 | $49.6M | 167 | 10% | N/A | N/A |
#10 | $7.6M | 35 | -8% | N/A | N/A |
What Is RnA ReSet Pro?
Dr. Carolyn Dean is a medical doctor and naturopath. She’s the author of over 35 books including best seller The Magnesium Miracle along with IBS for Dummies, Hormone Balance, Death by Modern Medicine, and 110 Kindle books. In 2015, she launched RnAReSet and brought her 40 years of experience into her proprietary, unique formulations that give every individual at any stage of wellness or illness the necessary building blocks for sustained health, vitality and well-being.
keywords:N/A
N/A
Total Funding
19
Number of Employees
$3.1M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RnA ReSet Pro News
B-cells also send out both pro- and anti-inflammatory signals. ... to identify the B-cell variations, namely RNA sequencing, DNA genotyping,...
Researchers used RNA sequencing, DNA genotyping, and assessment of ... Activated B-cells then produce antibodies, and also secrete pro- and...
Other Companies in Mooresville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 20 | 0% | N/A |
#2 | N/A | 22 | 5% | N/A |
#3 | $3.8M | 24 | -17% | N/A |
#4 | $4.3M | 25 | -11% | N/A |
#5 | $3.5M | 25 | -4% | N/A |